Is this you? Create Your Porfile
Avatar

Michael Christopher VanZandt

Bayer Corporation

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Michael Christopher VanZandt is active.

Explore More

Publication

Featured researches published by Michael Christopher VanZandt.

Archive | 1995

Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors

Harold C. E. Kluender; Guenter Hans Heinz Herbert Benz; David Ross Brittelli; William H. Bullock; Kerry Jeanne Combs; Brian R. Dixon; Stephan Schneider; Jill Elizabeth Wood; Michael Christopher VanZandt; Donald John Wolanin; Scott M. Wilhelm

Archive | 1999

Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer

Hanno Roder; Timothy B. Lowinger; David Ross Brittelli; Michael Christopher VanZandt

Archive | 2001

Inhibition of matrix metalloproteases by substitued biaryl oxobutyric acids

Michael Christopher VanZandt; David Ross Brittelli; Brian R. Dixon

Archive | 1997

Substituted cycloalkanecarboxylic acid derivatives as matrix metalloprotease inhibitors

Harold C. E. Kluender; Guenter Hans Herbert Heinz Benz; Kerry Jeanne Combs; Brian R. Dixon; Michael Christopher VanZandt; Scott M. Wilhelm; Donald John Wolanin; Jill Elizabeth Wood; Stephan Schneider

Archive | 1995

Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors

Harold C. E. Kluender; Guenter Hans Heinz Herbert Benz; David Ross Brittelli; William H. Bullock; Kerry Jeanne Combs; Brian R. Dixon; Stephan Schneider; Jill Elizabeth Wood; Michael Christopher VanZandt; Donald John Wolanin; Scott M. Wilhelm

Archive | 1998

Substituted 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors

Harold C. E. Kluender; Guenter Hans Heinz Herbert Benz; David Ross Brittelli; William H. Bullock; Kerry Jeanne Combs; Brian R. Dixon; Stephan Schneider; Jill Elizabeth Wood; Michael Christopher VanZandt; Donald John Wolanin; Scott M. Wilhelm

Archive | 1997

Substituted oxobutyric acids as matrix metalloprotease inhibitors

Brian R. Dixon; Jinshan Chen; Michael Christopher VanZandt; David Ross Brittelli

Archive | 1997

Thiophenebutanoic acid derivatives as matrix metalloprotease inhibitors

Harold C. E. Kluender; Guenter Hans Herbert Heinz Benz; William H. Bullock; Brian R. Dixon; Michael Christopher VanZandt; Scott M. Wilhelm; Donald John Wolanin; Jill Elizabeth Wood; David Ross Brittelli

Archive | 1997

Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease inhibitors

Harold C. E. Kluender; Guenter Hans Herbert Heinz Benz; David Ross Brittelli; Brian R. Dixon; Michael Christopher VanZandt; Scott M. Wilhelm; Donald John Wolanin

Archive | 1999

Derives d'indolocarbazole utiles pour le traitement de troubles de neurodegenerescence et du cancer

Hanno Roder; Timothy B. Lowinger; David R. Brittelli; Michael Christopher VanZandt

Explore More

Collaboration

Dive into the Michael Christopher VanZandt's collaboration.

Top Co-Authors
Avatar

Brian R. Dixon

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

Harold C. E. Kluender

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

David Ross Brittelli

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

Kerry Jeanne Combs

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

Stephan Schneider

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

William H. Bullock

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

Donald John Wolanin

Bayer

View shared research outputs
Top Co-Authors
Avatar

Scott M. Wilhelm

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

Jill Elizabeth Wood

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

Guenter Hans Heinz Herbert Benz

Bayer Corporation

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge